This CME Symposium takes place on November 17, 2014, from 6:30 PM - 9:00 PM at the Chicago Marriott, Downtown Magnificent Mile.
PRLog - Oct. 16, 2014 - CHICAGO -- Click to Register Online
Stable Ischemic Heart Disease Management:
Challenges and Controversies
Valentin Fuster (Co-Chair)
Professor of Medicine
Icahn School of Medicine
at Mount Sinai
New York, New York
Peter Stone, MD (Co-Chair)
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Mikhail Kosiborod, MD
Professor of Medcine
University of Missouri Kansas City
School of Medicine
Kansas City, Missouri
L. Kristin Newby, MD, MHS
Professor of Medicine
Duke University
Durham, North Carolina
Duane Pinto, MD, MPH
Assistant Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Click to Register Online
The evolution of stable ischemic heart disease (SIHD) management has included changes and new information in all aspects of management, including but not limited to diagnosis and assessment of risk, guideline directed medical therapy (GDMT), cardiometabolic risk factor control, when to revascularize the SIHD patient, and when revascularization is selected, and decision-making regarding percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG). SIHD guidelines indicate that the objectives of treatment are to 1) reduce premature cardiovascular death; 2) prevent complications of SIHD that directly or indirectly impair patients’ functional well-being, including nonfatal acute myocardial infarction (AMI) and heart failure; 3) maintain or restore a level of activity, functional capacity, and quality of life that is satisfactory to the patient; 4) completely, or nearly completely, eliminate ischemic symptoms; and 5) minimize costs of health care, in particular by eliminating avoidable adverse effects of tests and treatments, by preventing hospital admissions, and by eliminating unnecessary tests and treatments. In this program, a faculty of experts—co-Chairs Dr. Valentin Fuster and Dr. Peter Stone, Dr. Mikhail Kosiborod, Dr. L. Kristin Newby, and Dr. Duane Pinto—will describe state-of-the-art management with GDMT and revascularization, discuss current controversies, and debate best practice in challenging cases of SIHD patients.
Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Voxmedia LLC designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Voxmedia gratefully acknowledges the educational grant provided by Gilead Sciences Medical Affairs.
This educational activity is intended for general and interventional cardiologists.
Pre-registration is for planning purposes only.
For additional CME activities and online cme courses visit CMEPlanet
Read Full Story - CME Symposium- Stable Ischemic Heart Disease Management: Challenges and Controversies | More news from this source
Press release distribution by PRLog
CME Symposium- Stable Ischemic Heart Disease Management: Challenges and Controversies
October 16, 2014 at 14:58 PM EDT